MeSH tree: C04.588.894.797.520
Breathing in wildfire pollution may make it harder for people with lung cancer to survive, according to a new study from UC Davis Comprehensive Cancer Center researchers.
May 28, 2025
0
14
Combining data across mismatched maps is a key challenge in global health and environmental research. A powerful modeling approach has been developed to enable faster and more accurate integration of spatially misaligned ...
May 27, 2025
0
14
Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells cluster around tumors. ...
It may seem an odd analogy, but managing a health issue is a lot like driving a car. We want the fastest, safest and most reliable journey possible.
May 15, 2025
0
12
A new artificial intelligence-based method accurately sorts cancer patients into groups that have similar characteristics before treatment and similar outcomes after treatment, according to a study led by investigators at ...
May 12, 2025
0
22
A study published in Scientific Reports reveals a significant prevalence of mental health concerns among Vietnamese family caregivers of lung cancer patients, highlighting the urgent need for targeted support.
May 9, 2025
0
19
An emerging oncology tool known as broad genomic profiling or BGP is increasingly being used to help identify targeted therapies for patients diagnosed with cancer.
May 8, 2025
0
14
Blocking proteins that cause cancer cells to mutate and resist treatment could significantly improve outcomes for some patients with non-small cell lung cancer (NSCLC), the most common type of lung cancer, according to a ...
May 5, 2025
0
15
Researchers have shown that activation of the protein YAP, known to help cancer cells survive treatment, behaves very differently in cell culture models depending on how they are grown in the lab, highlighting the importance ...
Apr 29, 2025
0
14
Patients with previously treated non-small cell lung cancer (NSCLC) whose tumors harbored a KRAS G12D mutation experienced clinical benefit from the oral KRAS G12D inhibitor zoldonrasib, according to results presented at ...
Apr 29, 2025
0
18
